Treatment Of Liver Disease With Mitochondrial Glycerol-3-Phosphate Acyltransferase (GPAM) Inhibitors

AU2026216796A1Pending Publication Date: 2026-09-10REGENERON PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026216796
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-08-13
Publication Date
2026-09-10
Patent Text Reader

Abstract

Abstract The present disclosure provides methods of treating subjects having liver disease, and methods of identifying subjects having an increased risk of developing liver disease. 20 26 21 67 96 13 A ug 2 02 6 2 0 2 6 2 1 6 7 9 6 1 3 2 0 2 6 A u g
Need to check novelty before this filing date? Find Prior Art